These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12606600

  • 21. Histamine H3 Receptor Antagonist Prevents Memory Deficits and Synaptic Plasticity Disruption Following Isoflurane Exposure.
    Luo T, Wang Y, Qin J, Liu ZG, Liu M.
    CNS Neurosci Ther; 2017 Apr; 23(4):301-309. PubMed ID: 28168839
    [Abstract] [Full Text] [Related]

  • 22. H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization.
    Komater VA, Browman KE, Curzon P, Hancock AA, Decker MW, Fox GB.
    Psychopharmacology (Berl); 2003 Jun; 167(4):363-72. PubMed ID: 12682709
    [Abstract] [Full Text] [Related]

  • 23. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats.
    Sadek B, Saad A, Subramanian D, Shafiullah M, Łażewska D, Kieć-Kononowiczc K.
    Neuropharmacology; 2016 Jul; 106():46-55. PubMed ID: 26525191
    [Abstract] [Full Text] [Related]

  • 24. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
    Zhang M, Ballard ME, Pan L, Roberts S, Faghih R, Cowart M, Esbenshade TA, Fox GB, Decker MW, Hancock AA, Rueter LE.
    Brain Res; 2005 May 31; 1045(1-2):142-9. PubMed ID: 15910772
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.
    Cowart M, Faghih R, Curtis MP, Gfesser GA, Bennani YL, Black LA, Pan L, Marsh KC, Sullivan JP, Esbenshade TA, Fox GB, Hancock AA.
    J Med Chem; 2005 Jan 13; 48(1):38-55. PubMed ID: 15634000
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Histamine H3 and H4 receptors as novel drug targets.
    Tiligada E, Zampeli E, Sander K, Stark H.
    Expert Opin Investig Drugs; 2009 Oct 13; 18(10):1519-31. PubMed ID: 19758107
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
    Faucard R, Armand V, Héron A, Cochois V, Schwartz JC, Arrang JM.
    J Neurochem; 2006 Sep 13; 98(5):1487-96. PubMed ID: 16923161
    [Abstract] [Full Text] [Related]

  • 36. Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.
    Brown DG, Bernstein PR, Griffin A, Wesolowski S, Labrecque D, Tremblay MC, Sylvester M, Mauger R, Edwards PD, Throner SR, Folmer JJ, Cacciola J, Scott C, Lazor LA, Pourashraf M, Santhakumar V, Potts WM, Sydserff S, Giguère P, Lévesque C, Dasser M, Groblewski T.
    J Med Chem; 2014 Feb 13; 57(3):733-58. PubMed ID: 24410637
    [Abstract] [Full Text] [Related]

  • 37. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA.
    J Pharmacol Exp Ther; 2005 Jul 13; 314(1):271-81. PubMed ID: 15821027
    [Abstract] [Full Text] [Related]

  • 38. Histamine H3 receptor antagonists: from target identification to drug leads.
    Bonaventure P, Letavic M, Dugovic C, Wilson S, Aluisio L, Pudiak C, Lord B, Mazur C, Kamme F, Nishino S, Carruthers N, Lovenberg T.
    Biochem Pharmacol; 2007 Apr 15; 73(8):1084-96. PubMed ID: 17129577
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
    Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Bioorg Med Chem; 2004 May 15; 12(10):2727-36. PubMed ID: 15110854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.